3.8 Article

Technical Update No. 439: Antenatal Corticosteroids at Late Preterm Gestation

Related references

Note: Only part of the references are listed.
Article Public, Environmental & Occupational Health

Improving the external validity of Antenatal Late Preterm Steroids trial findings

Jennifer A. Hutcheon et al.

Summary: This study estimated the real-world absolute risk reduction and number-needed-to-treat (NNT) for antenatal corticosteroids at late preterm ages, taking into account the differences in gestational age between the trial participants and the real-world population. The results showed a lower absolute risk reduction and NNT in the real-world setting compared to the trial data, and also highlighted the differences in benefits between using corticosteroids at 34 weeks and 36 weeks.

PAEDIATRIC AND PERINATAL EPIDEMIOLOGY (2023)

Article Obstetrics & Gynecology

Neurodevelopmental outcomes after late preterm antenatal corticosteroids: the alps follow-up study

Cynthia Gyamfi-Bannerman

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2023)

Review Obstetrics & Gynecology

A Growing Dilemma: Antenatal Corticosteroids and Long-Term Consequences

Elizabeth Asztalos et al.

Summary: Synthetic antenatal corticosteroids are commonly used in women at risk for preterm birth before 34 weeks of gestation, but there are concerns about their potential long-term effects on the fetal brain. Further research is needed to gather sufficient safety data, both short term and long term. Caution should be exercised in the use of antenatal corticosteroids until dosing strategies can be optimized and better identification of women at risk of preterm birth is achieved.

AMERICAN JOURNAL OF PERINATOLOGY (2022)

Article Pediatrics

Antenatal corticosteroids and neurodevelopmental outcomes in late preterm births

Amir Aviram et al.

Summary: In a retrospective cohort study conducted in Ontario, Canada between 2006 and 2011, exposure to antenatal corticosteroids earlier in gestation was associated with an increased risk for neurodevelopmental concerns and healthcare utilization at ages 5-9 among children born during the late preterm period. This study adds to concerns regarding the long-term safety of antenatal corticosteroid use, particularly in late preterm infants.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2022)

Article Obstetrics & Gynecology

Antenatal corticosteroids to reduce neonatal morbidity and mortality Green-top Guideline No. 74

S. J. Stock et al.

BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2022)

Article Medicine, General & Internal

Antenatal corticosteroid administration and attention-deficit/hyperactivity disorder in childhood: a regression discontinuity study

Jennifer A. Hutcheon et al.

Summary: This study aimed to investigate the impact of fetal exposure to antenatal corticosteroids on the prescription rate of attention-deficit/hyperactivity disorder (ADHD) medication in childhood. By using a quasiexperimental design and analyzing the data, it was found that there was no significant correlation between fetal exposure to antenatal corticosteroids and the prescription rate of ADHD medication.

CANADIAN MEDICAL ASSOCIATION JOURNAL (2022)

Article Medicine, General & Internal

Association of Neonatal Hypoglycemia With Academic Performance in Mid-Childhood

Rajesh Shah et al.

Summary: This prospective cohort study examined the association between neonatal hypoglycemia and low educational achievement at age 9 to 10 years among infants at risk of hypoglycemia. The results showed that exposure to neonatal hypoglycemia was not significantly associated with lower educational achievement in mid-childhood among participants who were screened and treated if needed.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2022)

Review Pediatrics

Evaluation of Long-term Outcomes Associated With Preterm Exposure to Antenatal Corticosteroids A Systematic Review and Meta-analysis

Kiran Ninan et al.

Summary: This study conducted a systematic review and meta-analysis to investigate the long-term outcomes associated with preterm exposure to antenatal corticosteroids in children. The findings suggest that while a single course of antenatal corticosteroids may reduce the risk of neurodevelopmental impairment in extremely preterm infants, it is associated with an increased risk of adverse neurocognitive and/or psychological outcomes in children born late-preterm and full-term. These findings highlight the need for caution in administering antenatal corticosteroids.

JAMA PEDIATRICS (2022)

Article Obstetrics & Gynecology

Society for Maternal-Fetal Medicine Consult Series #58: Use of antenatal corticosteroids for individuals at risk for late preterm delivery

Uma M. Reddy et al.

Summary: The use of antenatal corticosteroids in the late preterm period before 35 weeks of gestation has been widely adopted to reduce neonatal morbidity. However, the long-term risks associated with their use remain uncertain. Recommendations suggest offering corticosteroids to high-risk patients meeting specific criteria, while cautioning against use in certain populations and advising thorough counseling on potential risks and benefits.

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2021)

Review Obstetrics & Gynecology

Neonatal and Maternal Outcomes of Lower Versus Standard Doses of Antenatal Corticosteroids for Women at Risk of Preterm Delivery: A Systematic Review of Randomized Controlled Trials

Kiran Ninan et al.

Summary: This study found limited data from randomized trials comparing lower doses of antenatal corticosteroids with standard double doses, indicating a need for further research. Concerns regarding current dosing patterns call for urgent randomized controlled trials comparing lower versus standard double doses of antenatal corticosteroids.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2021)

Review Pediatrics

Antenatal corticosteroids: a reappraisal of the drug formulation and dose

Alan H. Jobe et al.

Summary: The history of antenatal corticosteroid therapy is reviewed, indicating inadequate evaluation and the need to minimize fetal exposure to medications. Recent experimental data show the importance of reducing fetal drug exposure to optimize outcomes. Studies suggest that the current dosing of corticosteroids may exceed the minimum exposure needed for fetal lung maturation.

PEDIATRIC RESEARCH (2021)

Article Endocrinology & Metabolism

No Association of Antenatal Synthetic Glucocorticoid Exposure and Hair Steroid Levels in Children and Adolescents

Liesa Ilg et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2020)

Article Medicine, General & Internal

Associations Between Maternal Antenatal Corticosteroid Treatment and Mental and Behavioral Disorders in Children

Katri Raikkonen et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Medicine, General & Internal

Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries

Olufemi T. Oladapo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Article Endocrinology & Metabolism

Persistent Effects of Antenatal Synthetic Glucocorticoids on Endocrine Stress Reactivity From Childhood to Adolescence

Liesa Ilg et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2019)

Article Pediatrics

The screening and management of newborns at risk for low blood glucose

Michael R. Narvey et al.

PAEDIATRICS & CHILD HEALTH (2019)

Article Obstetrics & Gynecology

No. 364-Antenatal Corticosteroid Therapy for Improving Neonatal Outcomes

Amanda Skoll et al.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY CANADA (2018)

Article Pediatrics

Association of Neonatal Glycemia With Neurodevelopmental Outcomes at 4.5 Years

Christopher J. D. McKinlay et al.

JAMA PEDIATRICS (2017)

Editorial Material Obstetrics & Gynecology

Antenatal corticosteroids for the late preterm infant and agnotology

J. W. Kaempf et al.

JOURNAL OF PERINATOLOGY (2017)

Article Medicine, General & Internal

Antenatal Betamethasone for Women at Risk for Late Preterm Delivery

C. Gyamfi-Bannerman et al.

NEW ENGLAND JOURNAL OF MEDICINE (2016)

Article Obstetrics & Gynecology

Committee Opinion No.677

OBSTETRICS AND GYNECOLOGY (2016)

Article Endocrinology & Metabolism

Antenatal glucocorticoid treatment is associated with diurnal cortisol regulation in term-born children

M. N. Edelmann et al.

PSYCHONEUROENDOCRINOLOGY (2016)

Article Environmental Sciences

Antenatal Dexamethasone Exposure in Preterm Infants Is Associated with Allergic Diseases and the Mental Development Index in Children

Wan-Ning Tseng et al.

INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH (2016)

Article Obstetrics & Gynecology

Neurodevelopmental outcome of extremely premature infants exposed to incomplete, no or complete antenatal steroids

Sanjay Chawla et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2013)

Article Obstetrics & Gynecology

Antenatal steroid exposure and pulmonary outcomes in adolescents born with very low birth weight

P. A. Nixon et al.

JOURNAL OF PERINATOLOGY (2013)

Article Obstetrics & Gynecology

Health consequences of prophylactic exposure to antenatal corticosteroids among children born late preterm or term

Lena Eriksson et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2012)

Article Endocrinology & Metabolism

Impact of Antenatal Synthetic Glucocorticoid Exposure on Endocrine Stress Reactivity in Term-Born Children

Nina Alexander et al.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)

Article Obstetrics & Gynecology

Antenatal dexamethasone has no adverse effects on child physical and cognitive development: a long-term cohort follow-up investigation

Jing Liu et al.

JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2012)

Article Psychiatry

Psychobiological Effects of Prenatal Glucocorticoid Exposure in 10-Year-Old-Children

Katja Erni et al.

Frontiers in Psychiatry (2012)

Editorial Material Oncology

Helping Patients Decide: Ten Steps to Better Risk Communication

Angela Fagerlin et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)

Article Medicine, General & Internal

Effectiveness of antenatal corticosteroids in reducing respiratory disorders in late preterm infants: randomised clinical trial

Ana Maria Feitosa Porto et al.

BMJ-BRITISH MEDICAL JOURNAL (2011)

Article Obstetrics & Gynecology

The Effect of Antenatal Steroids on Fetal Lung Maturation between the 34th and 36th Week of Pregnancy

Osman Balci et al.

GYNECOLOGIC AND OBSTETRIC INVESTIGATION (2010)

Article Obstetrics & Gynecology

Short and long-term effects of antenatal corticosteroids assessed in a cohort of 7,827 children born preterm

Lena Eriksson et al.

ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2009)

Article Pediatrics

Antenatal glucocorticoid treatment is not associated with long-term metabolic risks in individuals born before 32 weeks of gestation

M. J. J. Finken et al.

ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION (2008)

Article Medicine, General & Internal

Outcomes at 2 years of age after repeat doses of antenatal corticosteroids

Caroline A. Crowther et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

Article Pediatrics

Twenty-year follow-up of antenatal corticosteroid treatment

AB Dessens et al.

PEDIATRICS (2000)